1. Home
  2. PAGS vs RCUS Comparison

PAGS vs RCUS Comparison

Compare PAGS & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PAGS

PagSeguro Digital Ltd.

HOLD

Current Price

$9.61

Market Cap

2.9B

Sector

Technology

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$23.87

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAGS
RCUS
Founded
2006
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PAGS
RCUS
Price
$9.61
$23.87
Analyst Decision
Buy
Buy
Analyst Count
7
8
Target Price
$11.71
$29.38
AVG Volume (30 Days)
3.7M
2.1M
Earning Date
02-19-2026
10-28-2025
Dividend Yield
1.44%
N/A
EPS Growth
16.68
N/A
EPS
1.37
N/A
Revenue
$3,662,823,389.00
$240,000,000.00
Revenue This Year
$14.61
N/A
Revenue Next Year
$5.39
N/A
P/E Ratio
$7.12
N/A
Revenue Growth
10.88
N/A
52 Week Low
$6.11
$6.50
52 Week High
$11.16
$26.40

Technical Indicators

Market Signals
Indicator
PAGS
RCUS
Relative Strength Index (RSI) 46.36 58.02
Support Level $9.61 $22.60
Resistance Level $9.86 $23.62
Average True Range (ATR) 0.24 1.12
MACD -0.03 -0.13
Stochastic Oscillator 26.79 61.57

Price Performance

Historical Comparison
PAGS
RCUS

About PAGS PagSeguro Digital Ltd.

PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: